Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: Design of experiments-guided development, characterization and in vitro evaluation-Reference-Cited by-同舟云学术

Inhalable paclitaxel nanoagglomerate dry powders for lung cancer chemotherapy: Design of experiments-guided development, characterization and in vitro evaluation

Published:2024-03 Issue: Volume:653 Page:123877
ISSN:0378-5173
Container-title:International Journal of Pharmaceutics
language:en
Short-container-title:International Journal of Pharmaceutics

Author:

Chan Ho Wan,Zhang Xinyue,Chow Stephanie,Lam David Chi Leung,Chow Shing Fung

Funder

University Grants Committee Research Grants Council

Innovation and Technology Commission

Health and Medical Research Fund

Publisher

Elsevier BV

Reference59 articles.

1. Comparison of peak inspiratory flow rate via the Breezhaler(R), Ellipta(R) and HandiHaler(R) dry powder inhalers in patients with moderate to very severe COPD: a randomized cross-over trial;Altman;BMC Pulm. Med.,2018

2. Curcumin in combination with anti-cancer drugs: A nanomedicine review;Batra;Pharmacol. Res.,2019

3. Particle size effect of curcumin nanosuspensions on cytotoxicity, cellular internalization, in vivo pharmacokinetics and biodistribution;Bi;Nanomedicine,2017

4. Synergistic interaction of paclitaxel and curcumin with cyclodextrin polymer complexation in human cancer cells;Boztas;Mol. Pharm.,2013

5. Endocytosis at the nanoscale;Canton;Chem. Soc. Rev.,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational Development of Fingolimod Nano-embedded Microparticles as Nose-to-Brain Neuroprotective Therapy for Ischemic Stroke;2024-08-19

2. Building respirable powder architectures: utilizing polysaccharides for precise control of particle morphology for enhanced pulmonary drug delivery;Expert Opinion on Drug Delivery;2024-06-02